Skip to main content

Digestive Diseases

  • Chapter
  • First Online:
Internal Medicine for Dental Treatments

Abstract

Gastric ulcers and duodenal ulcers are called peptic ulcers because they both cause damage to their own tissues by the strong digestive effects of gastric acid and pepsin. Although peptic ulcer is a benign disease, the most serious problem is that patients have to be hospitalized for bleeding, perforation, and stricture and that the disease recurs even after healing. However, the involvement of Helicobacter pylori (H. pylori) in the pathogenesis of peptic ulcer and the fact that H. pylori eradication therapy almost completely suppresses ulcer recurrence have changed the concept of this disease. While H. pylori eradication therapy is widely used and the rate of H. pylori infection is decreasing, the use of non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin has been increasing year by year, and these drugs have become an important cause of peptic ulcer in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Asaka M, Sugano K, Chiba T, editors. Gastroenterology (Shokakibyou-gaku). Tokyo: Nishimurashoten; 2013. p. 658–65. (in Japanese).

    Google Scholar 

  2. Yazaki Y, editor. Practice of internal medicine (Shin Rinsyo Naika-gaku). 10th ed. Tokyo: Igaku-shoin; 2020. p. 499–501. (in Japanese).

    Google Scholar 

  3. The Japanese Society of Gastroenterology, editor. Evidence-based clinical practice guidelines for peptic ulcer 2020. 3rd ed. Tokyo: Nanko-do; 2020.

    Google Scholar 

  4. Hammad TA, et al. Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs. Pharmacoepidemiol Drug Saf. 2008;17(4):315–21.

    Article  PubMed  Google Scholar 

  5. Sugano K, et al. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol. 2012;47(5):540–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chan FK, et al. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol. 2008;103(11):2908–18.

    Article  CAS  PubMed  Google Scholar 

  7. Chaitanya B, et al. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis. Oral Oncol. 2017;72:179–82.

    Article  CAS  PubMed  Google Scholar 

  8. Yatsuhashi H. Current trends in viral hepatitis - prevention of viral hepatitis. J Jpn Med Assoc. 2020;148(11):2185–9. (in Japanese).

    CAS  Google Scholar 

  9. Sasaki H. Recent advance in the treatment of chronic viral hepatitis. J Jpn Soc Intern Med. 2018;107(3):431–7. (in Japanese).

    Article  CAS  Google Scholar 

  10. Garner JS, The Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospitals. Am J Infect Control. 1996;24:24–31.

    Article  CAS  PubMed  Google Scholar 

  11. CDC. Guidelines for infection control in dental health-care settings-2003. MMWR. 2003;52:1–61.

    Google Scholar 

  12. Japanese Association for Dental Science. Ministry of Health, Labour and Welfare Commissioned Project “Verification of nosocomial infection control in dental practice” guidelines for nosocomial infection control in general dental practice. 2nd ed. Tokyo: Japanese Association for Dental Science; 2019. (in Japanese). https://www.mhlw.go.jp/content/000510471.pdf. Accessed 30 Jan 2022.

    Google Scholar 

  13. Japan Dental Association, editor. Evidence-based practical manual for nosocomial infection control in general dentistry. (Evidence ni Motoduku Ippan Shika Shinryou niokeru Innai Kansen Taisaku Jissen Manual). Kyoto: Nagasueshoten; 2007. (in Japanese).

    Google Scholar 

  14. The Japan Society of Hepatology, Nishiguchi S, general editor. Cirrhosis of the liver by etiology 2018. (Kankouhen no Seiinbetsu Jittai 2018). Tokyo: Igakutosyo Shuppan; 2019. (in Japanese).

    Google Scholar 

  15. The Japan Society of Hepatology, editor. Medical guide for chronic hepatitis and cirrhosis 2019. (Mansei Kanen Kankouhen no Shinryo guide 2019). Tokyo: Bunko-do; 2019. (in Japanese).

    Google Scholar 

  16. The Japanese Society of Gastroenterology, editor. Guidelines for the treatment of liver cirrhosis 2015. (Kankouhen Shinryo Guideline 2015). Tokyo: Bunko-do; 2015. (in Japanese).

    Google Scholar 

  17. The Japanese Society of Gastroenterology, editor. Evidence-based Clinical Practice Guidelines for Gastroesophageal Reflux Disease (GERD) 2021. (Ishokudou Gyakuryu-shou (GERD) Shinryo Guideline 2021). 3rd edn. Tokyo: Nanko-do; 2015. (in Japanese).

    Google Scholar 

  18. Kinoshita Y. ed. New diagnosis and treatment ABC77/gastrointestinal 11 functional esophageal diseases - GERD and functional esophageal disorders - 2013 latest medical Supplement. (Atarashii Shindan to Chiryou no ABC77/Shoukaki 11, Kinousei Shokudou Shikkan – GERD to Kinousei Shokudou Shougai- 2013 nenn Saishin Igaku Bessatsu). Osakae: Saishin Igaku-sya; 2013. (in Japanese).

    Google Scholar 

  19. Kinoshita Y, et al. Future perspective of research and clinical practice in gastroesophageal reflux disease. (GERD no Kenkyuu to Shinryo niokeru Kongono Tenkai). J Jpn Soc Gastroenterol. 2017;114(10):1765–73. (in Japanese).

    Google Scholar 

  20. Kinoshita Y., et al., editors., Takigawa H, general editor. Practice of functional gastrointestinal care. (Kinousei Shoukakan Shinryou no Jissai). J Jpn Med Assoc. 2019;147(10). (in Japanese).

    Google Scholar 

  21. Miyawaki S, Lavigne GJ, et al. Association between sleep bruxism, swallowing-related laryngeal movement, and sleep positions. Sleep. 2003;26(4):461–5.

    PubMed  Google Scholar 

  22. da Silveira MCM, Dalberto C, et al. Association between sleep bruxism and gastroesophageal reflux disease. J Prosthet Dent. 2013;110(5):349–55.

    Article  Google Scholar 

  23. Ohmure H. Oikawa K et al.Influence of experimental esophageal acidification on sleep bruxism: a randomized trial J Dent Res. 90(5): 665–671. 2011.

    Google Scholar 

  24. Kanematsu K, Ohmure H, et al. Evaluation of therapeutic effects of proton pump inhibitor for sleep bruxism: a randomized, double-blind, placebo-controlled, crossover study. (Suiminji bruxism nitaisuru proton pump Sogaizai no Chiryoukoukano Kento: placebo Taisyou Nijyuouken crossover Hikakushiken). J Jpn Soc Stomatognath Funct. 2014;21(1):38–9. (in Japanese).

    Article  Google Scholar 

  25. The Japanese Society of Gastroenterology, editor. Evidence-based clinical practice guidelines for inflammatory bowel disease (IBD) 2020. 2nd edn. (Enshousei Cyoushikkann (IBD) Shindan Guideline 2020). Tokyo: Nanko-do; 2020. (in Japanese).

    Google Scholar 

  26. Health and Labor Sciences Research Grants, Intractable Disease Policy Research Project. Research on intractable inflammatory bowel disease (Suzuki group) in diagnostic criteria and treatment guidelines for ulcerative colitis and Crohn’s disease, revised edn; 2020. (in Japanese). doc01.pdf (ibdjapan.org).

  27. Omata M, Chiba T, editors. Gastroenterology for medical specialists. (Senmoni notameno Shoukakibyou-gaku). 3rd ed. Tokyo: Igakushoin; 2021. (in Japanese).

    Google Scholar 

  28. Ng SC, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.

    Article  PubMed  Google Scholar 

  29. Thomas T, et al. Epidemiology, morbidity and mortality in Behçet’s disease: a cohort study using The Health Improvement Network (THIN). Rheumatology. 2020;59:2785–95.

    Article  PubMed  Google Scholar 

  30. Skef W, et al. Gastrointestinal Bechet’s disease: a review. World J Gastroenterol. 2015;21:3801–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Watanabe K, et al. The review of intestinal Behçetʼs disease: from epidemiology and diagnosis to future issue. Nihon Shokakibyo Gakkai Zasshi. 2022;119:217–26. (in Japanese).

    PubMed  Google Scholar 

  32. Japanese Society for Cancer of the Colon and Rectum, editor. JSCCR guidelines 2020 for the clinical practice of hereditary colorectal cancer. (Idensei Daichougan Shinryo guideline). Tokyo: Kanehara Shuppan; 2020. (in Japanese).

    Google Scholar 

  33. Jenne DE, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18:38–44.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jiro Nishida .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kudo, T. et al. (2023). Digestive Diseases. In: Chiba, T., Yamada, H. (eds) Internal Medicine for Dental Treatments. Springer, Singapore. https://doi.org/10.1007/978-981-99-3296-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-3296-2_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-3295-5

  • Online ISBN: 978-981-99-3296-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics